[1]
Sandomenico, A.; Ruvo, M. Targeting Nodal and Cripto-1: perspectives inside dual potential theranostic cancer biomarkers. Curr. Med. Chem., 2019, 26(11), 1994-2050.
[2]
Squeglia, F.; Bachert, B.; De Simone, A.; Lukomski, S.; Berisio, R. The crystal structure of the streptococcal collagen-like protein 2 globular domain from invasive M3-type group A Streptococcus shows significant similarity to immunomodulatory HIV protein gp41. J. Biol. Chem., 2014, 289(8), 5122-5133.
[3]
Lukomski, S.; Bachert, B.A.; Squeglia, F.; Berisio, R. Collagen-like proteins of pathogenic streptococci. Mol. Microbiol., 2017, 103(6), 919-930.
[4]
McNitt, D.H.; Van De Water, L.; Marasco, D.; Berisio, R.; Lukomski, S. Streptococcal collagen-like protein 1 binds wound fibronectin: Implications in pathogen targeting. Curr. Med. Chem., 2019, 26(11), 1933-1945.
[5]
Esposito, C.; Pethoukov, M.V.; Svergun, D.I.; Ruggiero, A.; Pedone, C.; Pedone, E.; Berisio, R. Evidence for an elongated dimeric structure of heparin-binding hemagglutinin from Mycobacterium tuberculosis. J. Bacteriol., 2008, 190(13), 4749-4753.
[6]
Squeglia, F.; Ruggiero, A.; De Simone, A.; Berisio, R. A structural overview of mycobacterial adhesins: Key biomarkers for diagnostics and therapeutics. Protein Sci., 2018, 27(2), 369-380.
[7]
Squeglia, F.; Ruggiero, A.; Berisio, R. Chemistry of peptidoglycan in Mycobacterium tuberculosis life cycle: An off-the-wall balance of synthesis and degradation. Chemistry, 2018, 24(11), 2533-2546.
[8]
De Maio, F.; Squeglia, F.; Goletti, D.; Delogu, G. The mycobacterial surface protein HBHA: A promising biomarker for tuberculosis. Curr. Med. Chem., 2019, 26(11), 2051-2060.
[9]
Larrouy-Maumus, G. Lipids as biomarkers of cancer and bacterial infections. Curr. Med. Chem., 2019, 26(11), 1924-1932.
[10]
Phan, L.M.T.; Tufa, L.T.; Kim, H.J.; Lee, J.; Park, T.J. Trends in diagnosis for active tuberculosis using nanomaterials. Curr. Med. Chem., 2019, 26(11), 1946-1959.